AB0263 CLINICAL AND LABORATORY FACTORS ASSOCIATED WITH THE RHEUMATOID CACHEXIA.

Author:

Papichev E.,Seewordova L.,Akhverdyan Y.,Polyakova J.,Zavodovsky В.

Abstract

BackgroundRheumatoid arthritis (RA) is associated with reduced physical performance capacity, leisure activities and self-service [1]. These changes are the results of the destruction of the joints, as well as the decrease in muscle strength, which is known as sarcopenia. However, patients with RA beset with a rheumatoid cachexia (RC), a specific form of sarcopenia, characterized with a decrease in fat-free mass index and an increase in fat mass index [2]. RC leads to a dramatic decrease in the life quality and increase in mortality rate [3].ObjectivesTo study the clinical and laboratory factors associated with the RC.Methods110 patients (102 females and 8 males) were enrolled in our study. All patients fulfilled the 2010 ACR/EULAR classification criteria for RA. Standard clinical, laboratory and instrumental examinations were performed. Additionally, hsCRP, ACPA, CTX-1, P1NP and 25(OH)D were defined. Dual-energy X-ray absorptiometry with Total Body program was performed. The diagnosis of RC was based on the next criteria: fat-free mass index less than 10th percentiles with fat mass index above 25th percentiles [2]. Statistical analysis was performed using a software package “Statistica 12.0”. Parametric parameters are presented as M±std.dev. (95% CI), non-parametrics as Me (Q1-Q3). Intragroup analysis of quantitative indicators was carried out using Student’s or Mann-Whitney test. The multiple logistic regression analysis was performed with a stepwise direct search procedure. Results are presented as odds ratio (OR) and 95% confidence interval (95% CI). ROC curve was plotted to assess the diagnostic significance of quantitative signs in predicting rheumatoid cachexia.ResultsMean patients age was 53,7±12,07 (10,8-13,7) years. More than 85% had severe of terminal progression of the RA. Most patients were RF (77,3%) and ACPA (67,3%) positive, had moderate disease activity (3,79 [2,89-4,40]), cartilage erosions (79%) and II (56,4%) functional class. RC was diagnosed in 25 patients. Prevalence of RC was lower in RF-negative patients (OR 0,11 (95% CI 0,01-0,83). Also, prevalence of RA was associated with the duration of RA (1,06 (1,01-1,11)). Mean cumulative dose of glucocorticoids (GCs) was higher in patients with RC (8,5 g [6,2-17,5 g]), than without (5,8 g [3,6-13,7 g]) (Z=-1,98; p=0,047). Mean daily dose of GCs was lower in patients with RC (5 mg [4-8 mg] and 8 mg [5-10 mg] (Z=2,58; p=0,01)). The median duration of RA was higher among patients with RC (14,0 years [9,0-22,0] vs 8,0 years [3,0-16,0] (Z=-2,18; p=0,029)).ROC-curve was employed to assess the significance of the RF-negativity and RA duration in the diagnosis of RC. Results are presented in Figure 1.Figure 1.ROC-curve for the RC based on the duration of RA and the presence of RF.The optimum cut-off point of 9,5 years of RA was defined using Youden’s J, with a sensitivity of 88% and specificity of 53%.ConclusionRC is associated with the duration of RA, positivity for RF, higher cumulative dose of GCs and lower daily dose of GCs. Due to clinical practice, higher doses of GCs are usually prescribed as a “bridge-therapy” at the start of the treatment or while switching the therapy. On the other side, patients with low daily dose of GCs are more often hormone dependent, with high total cumulative dose. With the sensitivity of 88% patients with the duration of RA 9,5 years and more have RC.References[1]Metsios GS, Kitas GD. Physical activity, exercise and rheumatoid arthritis: effectiveness, mechanisms and implementation. Best Practice & Research Clinical Rheumatology. 2018; 32(5):669-682.[2]Coin A, Sergi G, Minicuci N, Giannini S, Barbiero E, Manzato E, et al. Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80 year-old Italian population. Clinical Nutrition. 2008; 27(1): 87-94.[3]Roubenoff R. Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century. Arthritis Research & Therapy. 2009; 11(2): 108.Disclosure of InterestsNone declared

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3